Protolabs Reports Financial Results for the Second Quarter of 2021
Record Revenue of
Second Quarter 2021 Highlights include:
-
Revenue for the second quarter of 2021 was
$123.0 million , representing a 15.5 percent increase compared to revenue of$106.6 million in the second quarter of 2020. -
Hubs generated
$8.9 million of revenue in the second quarter, representing growth of 45.6 percent over the second quarter of 2020. -
Net income for the second quarter of 2021 was
$12.9 million , or$0.47 per diluted share. -
Non-GAAP net income was
$10.7 million , or$0.39 per diluted share. See “Non-GAAP Financial Measures” below.
“During the second quarter of 2021, we experienced strong demand, and delivered record revenues despite the challenges of labor availability in the US. We are emerging from the pandemic stronger than ever in the custom parts space,” said
Additional Second Quarter 2021 Highlights include:
- Protolabs served 23,253 unique product developers during the quarter, representing a 36.5 percent increase over the second quarter of 2020.
- Gross margin in the second quarter of 2021 was 46.0 percent of revenue; Non-GAAP gross margin was 46.8 percent of revenue. See “Non-GAAP Financial Measures” below.
- EBITDA margin was 21.3 percent of revenue in the second quarter of 2021; adjusted EBITDA margin was 18.8 percent of revenue in the second quarter of 2021. See “Non-GAAP Financial Measures” below.
-
Cash and investments balance was
$89.0 million as ofJune 30, 2021 .
“The environment is ripe for growth and our digital manufacturing model is leading the way,” added
Non-GAAP Financial Measures
The company has included non-GAAP revenue growth that excludes the impact of changes in foreign currency exchange rates and revenue earned from our acquisition of Hubs (collectively, “non-GAAP revenue growth”). Management believes these metrics are useful in evaluating the underlying business trends and ongoing operating performance of the company.
The company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, and transaction costs (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the company’s financial results.
The company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, and transaction costs (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the company’s financial results.
The company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, and transaction costs (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the company’s financial results.
The company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP operating margin, non-GAAP revenue growth and Adjusted EBITDA, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the company’s management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the company’s business. Accordingly, the company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.
Conference Call
The company has scheduled a conference call to discuss its second quarter 2021 financial results and third quarter 2021 outlook today,
About Protolabs
Protolabs is the world’s leading digital manufacturing source for rapid prototyping and on-demand production. The technology-enabled company produces custom components in as fast as 1 day with automated 3D printing, CNC machining, sheet metal fabrication, and injection molding processes. Its digital approach to manufacturing enables accelerated time to market, reduces manufacturing costs, and enables supply chain agility throughout the product life cycle. Visit protolabs.com for more information.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the
| Condensed Consolidated Balance Sheets | ||||||
| (In thousands) | ||||||
|
|
|
|
||||
|
|
2021 |
|
|
2020 |
||
|
(Unaudited) |
|
|
||||
| Assets | ||||||
| Current assets | ||||||
| Cash and cash equivalents |
$ |
41,909 |
$ |
127,603 |
||
| Short-term marketable securities |
|
18,341 |
|
34,088 |
||
| Accounts receivable, net |
|
83,470 |
|
57,877 |
||
| Inventory |
|
9,111 |
|
10,862 |
||
| Income taxes receivable |
|
4,575 |
|
540 |
||
| Prepaid expenses and other current assets |
|
10,107 |
|
11,032 |
||
| Total current assets |
|
167,513 |
|
242,002 |
||
| Property and equipment, net |
|
288,495 |
|
282,666 |
||
|
|
407,191 |
|
128,752 |
|||
| Other intangible assets, net |
|
41,674 |
|
14,350 |
||
| Long-term marketable securities |
|
28,700 |
|
59,357 |
||
| Operating lease assets |
|
8,801 |
|
9,855 |
||
| Finance lease assets |
|
2,147 |
|
2,396 |
||
| Other long-term assets |
|
4,769 |
|
4,826 |
||
| Total assets |
$ |
949,290 |
$ |
744,204 |
||
| Liabilities and shareholders' equity | ||||||
| Current liabilities | ||||||
| Accounts payable |
$ |
26,038 |
$ |
18,248 |
||
| Accrued compensation |
|
14,930 |
|
11,989 |
||
| Accrued liabilities and other |
|
15,072 |
|
16,193 |
||
| Current contingent consideration |
|
2,936 |
|
- |
||
| Current operating lease liabilities |
|
2,847 |
|
3,272 |
||
| Current finance lease liabilities |
|
554 |
|
552 |
||
| Income taxes payable |
|
40 |
|
- |
||
| Total current liabilities |
|
62,417 |
|
50,254 |
||
| Long-term contingent consideration |
|
2,693 |
|
- |
||
| Long-term operating lease liabilities |
|
7,097 |
|
7,586 |
||
| Long-term finance lease liabilities |
|
1,639 |
|
1,919 |
||
| Long-term deferred tax liabilities |
|
36,898 |
|
33,854 |
||
| Other long-term liabilities |
|
6,569 |
|
6,235 |
||
| Shareholders' equity |
|
831,977 |
|
644,356 |
||
| Total liabilities and shareholders' equity |
$ |
949,290 |
$ |
744,204 |
||
| Condensed Consolidated Statements of Operations | ||||||||||||
| (In thousands, except share and per share amounts) | ||||||||||||
| (Unaudited) | ||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||
|
|
|
|||||||||||
|
|
2021 |
|
2020 |
|
2021 |
|
|
2020 |
||||
| Revenue | ||||||||||||
| Injection Molding |
$ |
58,168 |
$ |
57,894 |
$ |
114,527 |
|
$ |
112,670 |
|||
| CNC Machining |
|
41,592 |
|
28,760 |
|
78,295 |
|
|
66,645 |
|||
| 3D Printing |
|
18,170 |
|
14,236 |
|
35,405 |
|
|
30,184 |
|||
| Sheet Metal |
|
4,717 |
|
4,669 |
|
9,936 |
|
|
10,318 |
|||
| Other |
|
401 |
|
1,016 |
|
1,011 |
|
|
1,866 |
|||
| Total revenue |
|
123,048 |
|
106,575 |
|
239,174 |
|
|
221,683 |
|||
| Cost of revenue |
|
66,423 |
|
54,119 |
|
127,219 |
|
|
111,127 |
|||
| Gross profit |
|
56,625 |
|
52,456 |
|
111,955 |
|
|
110,556 |
|||
| Operating expenses | ||||||||||||
| Marketing and sales |
|
21,044 |
|
16,936 |
|
40,524 |
|
|
35,116 |
|||
| Research and development |
|
11,060 |
|
8,648 |
|
23,241 |
|
|
17,635 |
|||
| General and administrative |
|
8,417 |
|
12,521 |
|
27,825 |
|
|
26,629 |
|||
| Total operating expenses |
|
40,521 |
|
38,105 |
|
91,590 |
|
|
79,380 |
|||
| Income from operations |
|
16,104 |
|
14,351 |
|
20,365 |
|
|
31,176 |
|||
| Other income (loss), net |
|
137 |
|
767 |
|
(176 |
) |
|
1,821 |
|||
| Income before income taxes |
|
16,241 |
|
15,118 |
|
20,189 |
|
|
32,997 |
|||
| Provision for income taxes |
|
3,326 |
|
2,511 |
|
3,562 |
|
|
6,406 |
|||
| Net income |
$ |
12,915 |
$ |
12,607 |
$ |
16,627 |
|
$ |
26,591 |
|||
| Net income per share: | ||||||||||||
| Basic |
$ |
0.47 |
$ |
0.47 |
$ |
0.60 |
|
$ |
1.00 |
|||
| Diluted |
$ |
0.47 |
$ |
0.47 |
$ |
0.60 |
|
$ |
0.99 |
|||
| Shares used to compute net income per share: | ||||||||||||
| Basic |
|
27,735,732 |
|
26,660,498 |
|
27,600,684 |
|
|
26,718,652 |
|||
| Diluted |
|
27,744,870 |
|
26,760,866 |
|
27,741,464 |
|
|
26,837,938 |
|||
| Condensed Consolidated Statements of Cash Flows | |||||||
| (In thousands) | |||||||
| (Unaudited) | |||||||
|
Six Months Ended |
|||||||
|
|
|||||||
|
|
2021 |
|
|
2020 |
|
||
| Operating activities | |||||||
| Net income |
$ |
16,627 |
|
$ |
26,591 |
|
|
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Depreciation and amortization |
|
20,127 |
|
|
15,855 |
|
|
| Stock-based compensation expense |
|
10,561 |
|
|
6,672 |
|
|
| Deferred taxes |
|
419 |
|
|
5,651 |
|
|
| Amortization of marketable securities |
|
261 |
|
|
129 |
|
|
| Realized gain on available-for-sale securities |
|
(117 |
) |
|
- |
|
|
| Other |
|
125 |
|
|
(854 |
) |
|
| Changes in operating assets and liabilities |
|
(19,511 |
) |
|
(627 |
) |
|
| Changes in fair value of contingent consideration |
|
(7,763 |
) |
|
- |
|
|
| Net cash provided by operating activities |
|
20,729 |
|
|
53,417 |
|
|
| Investing activities | |||||||
| Purchases of property, equipment and other capital assets |
|
(23,929 |
) |
|
(33,305 |
) |
|
| Cash used for acquisitions, net of cash acquired |
|
(127,413 |
) |
|
- |
|
|
| Purchases of other assets and investments |
|
- |
|
|
(3,000 |
) |
|
| Purchases of marketable securities |
|
(15,159 |
) |
|
(57,212 |
) |
|
| Proceeds from sales of marketable securities |
|
47,694 |
|
|
- |
|
|
| Proceeds from maturities of marketable securities |
|
13,725 |
|
|
28,225 |
|
|
| Net cash used in investing activities |
|
(105,082 |
) |
|
(65,292 |
) |
|
| Financing activities | |||||||
| Proceeds from exercises of stock options and other |
|
3,838 |
|
|
2,855 |
|
|
| Purchases of shares withheld for tax obligations |
|
(4,209 |
) |
|
(3,367 |
) |
|
| Repurchases of common stock |
|
(1,210 |
) |
|
(14,686 |
) |
|
| Principal repayments of finance lease obligations |
|
(275 |
) |
|
- |
|
|
| Net cash used in financing activities |
|
(1,856 |
) |
|
(15,198 |
) |
|
| Effect of exchange rate changes on cash and cash equivalents |
|
515 |
|
|
(149 |
) |
|
| Net decrease in cash and cash equivalents |
|
(85,694 |
) |
|
(27,222 |
) |
|
| Cash and cash equivalents, beginning of period |
|
127,603 |
|
|
125,225 |
|
|
| Cash and cash equivalents, end of period |
$ |
41,909 |
|
$ |
98,003 |
|
|
| Reconciliation of GAAP to Non-GAAP Net Income per Share | ||||||||||||||||
| (In thousands, except share and per share amounts) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||||
|
|
|
|||||||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|||||
| Non-GAAP net income, adjusted for stock-based compensation expense, | ||||||||||||||||
| amortization expense, unrealized (gain) loss on foreign currency and | ||||||||||||||||
| transaction costs | ||||||||||||||||
| GAAP net income |
$ |
12,915 |
|
$ |
12,607 |
|
$ |
16,627 |
|
$ |
26,591 |
|
||||
| Add back: | ||||||||||||||||
| Stock-based compensation expense |
|
4,941 |
|
|
3,639 |
|
|
10,561 |
|
|
6,672 |
|
||||
| Amortization expense |
|
1,490 |
|
|
754 |
|
|
3,033 |
|
|
1,508 |
|
||||
| Unrealized (gain) loss on foreign currency |
|
(402 |
) |
|
(139 |
) |
|
220 |
|
|
(936 |
) |
||||
| Transaction costs 1 |
|
(7,655 |
) |
|
- |
|
|
(5,140 |
) |
|
- |
|
||||
| Total adjustments 2 |
|
(1,626 |
) |
|
4,254 |
|
|
8,674 |
|
|
7,244 |
|
||||
| Income tax benefits on adjustments 3 |
|
(575 |
) |
|
(987 |
) |
|
(3,576 |
) |
|
(1,662 |
) |
||||
| Non-GAAP net income |
$ |
10,714 |
|
$ |
15,874 |
|
$ |
21,725 |
|
$ |
32,173 |
|
||||
| Non-GAAP net income per share: | ||||||||||||||||
| Basic |
$ |
0.39 |
|
$ |
0.60 |
|
$ |
0.79 |
|
$ |
1.20 |
|
||||
| Diluted |
$ |
0.39 |
|
$ |
0.59 |
|
$ |
0.78 |
|
$ |
1.20 |
|
||||
| Shares used to compute non-GAAP net income per share: | ||||||||||||||||
| Basic |
|
27,735,732 |
|
|
26,660,498 |
|
|
27,600,684 |
|
|
26,718,652 |
|
||||
| Diluted |
|
27,744,870 |
|
|
26,760,866 |
|
|
27,741,464 |
|
|
26,837,938 |
|
||||
| 1 Transaction costs include direct costs incurred in our acquisition of |
||||||||||||||||
| 2 Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and transaction costs were included in the following GAAP consolidated statement of operations categories: | ||||||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||||
|
|
|
|||||||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|||||
| Cost of revenue |
$ |
1,011 |
|
$ |
936 |
|
$ |
1,988 |
|
$ |
1,799 |
|
||||
| Marketing and sales |
|
929 |
|
|
750 |
|
|
1,782 |
|
|
1,368 |
|
||||
| Research and development |
|
744 |
|
|
607 |
|
|
1,368 |
|
|
1,128 |
|
||||
| General and administrative |
|
(3,908 |
) |
|
2,100 |
|
|
3,316 |
|
|
3,885 |
|
||||
| Total operating expenses |
|
(2,235 |
) |
|
3,457 |
|
|
6,466 |
|
|
6,381 |
|
||||
| Other (income) loss, net |
|
(402 |
) |
|
(139 |
) |
|
220 |
|
|
(936 |
) |
||||
| Total adjustments |
$ |
(1,626 |
) |
$ |
4,254 |
|
$ |
8,674 |
|
$ |
7,244 |
|
||||
| 3 For the three and six-month periods ended |
||||||||||||||||
| Reconciliation of GAAP to Non-GAAP Operating Margin | ||||||||||||||||
| (In thousands) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||||
|
|
|
|||||||||||||||
|
2021 |
2020 |
2021 |
2020 |
|||||||||||||
| Revenue |
$ |
123,048 |
|
$ |
106,575 |
|
$ |
239,174 |
|
$ |
221,683 |
|
||||
| Income from operations |
|
16,104 |
|
|
14,351 |
|
|
20,365 |
|
|
31,176 |
|
||||
| GAAP operating margin |
|
13.1 |
% |
|
13.5 |
% |
|
8.5 |
% |
|
14.1 |
% |
||||
| Add back: | ||||||||||||||||
| Stock-based compensation expense |
|
4,941 |
|
|
3,639 |
|
|
10,561 |
|
|
6,672 |
|
||||
| Amortization expense |
|
1,490 |
|
|
754 |
|
|
3,033 |
|
|
1,508 |
|
||||
| Transaction costs 1 |
|
(7,655 |
) |
|
- |
|
|
(5,140 |
) |
|
- |
|
||||
| Total adjustments |
|
(1,224 |
) |
|
4,393 |
|
|
8,454 |
|
|
8,180 |
|
||||
| Non-GAAP income from operations |
$ |
14,880 |
|
$ |
18,744 |
|
$ |
28,819 |
|
$ |
39,356 |
|
||||
| Non-GAAP operating margin |
|
12.1 |
% |
|
17.6 |
% |
|
12.0 |
% |
|
17.8 |
% |
||||
|
1 Transaction costs include direct costs incurred in our acquisition of |
||||||||||||||||
| Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA | ||||||||||||||||
| (In thousands) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||||
|
|
|
|
||||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||
| GAAP net income |
$ |
12,915 |
|
$ |
12,607 |
|
$ |
16,627 |
|
$ |
26,591 |
|
||||
| Amortization expense |
|
1,490 |
|
|
754 |
|
|
3,033 |
|
|
1,508 |
|
||||
| Depreciation expense |
|
8,578 |
|
|
7,143 |
|
|
17,094 |
|
|
14,347 |
|
||||
| Interest income, net |
|
(65 |
) |
|
(368 |
) |
|
(152 |
) |
|
(928 |
) |
||||
| Tax expense |
|
3,326 |
|
|
2,511 |
|
|
3,562 |
|
|
6,406 |
|
||||
| EBITDA |
|
26,244 |
|
|
22,647 |
|
|
40,164 |
|
|
47,924 |
|
||||
| Add back: | ||||||||||||||||
| Stock-based compensation expense |
|
4,941 |
|
|
3,639 |
|
|
10,561 |
|
|
6,672 |
|
||||
| Unrealized (gain) loss on foreign currency |
|
(402 |
) |
|
(139 |
) |
|
220 |
|
|
(936 |
) |
||||
| Transaction costs 1 |
|
(7,655 |
) |
|
- |
|
|
(5,140 |
) |
|
- |
|
||||
| Total adjustments |
|
(3,116 |
) |
|
3,500 |
|
|
5,641 |
|
|
5,736 |
|
||||
| Adjusted EBITDA |
$ |
23,128 |
|
$ |
26,147 |
|
$ |
45,805 |
|
$ |
53,660 |
|
||||
| 1 Transaction costs include direct costs incurred in our acquisition of |
||||||||||||||||
| Comparison of GAAP to Non-GAAP Revenue Growth | |||||||||||||||||||||||
| (In thousands) | |||||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||
|
Three Months Ended
|
Three Months Ended
|
% |
|||||||||||||||||||||
|
GAAP |
Foreign Currency1 |
Hubs Acquisition2 |
Non-GAAP |
GAAP |
Change3 |
% Change Organic4 |
|||||||||||||||||
| Revenues | |||||||||||||||||||||||
|
$ |
95,344 |
$ |
- |
|
$ |
(4,626 |
) |
$ |
90,718 |
$ |
86,823 |
9.8 |
% |
4.5 |
% |
||||||||
|
|
24,655 |
|
(1,913 |
) |
|
(4,314 |
) |
|
18,428 |
|
16,729 |
47.4 |
|
10.2 |
|
||||||||
|
|
3,049 |
|
54 |
|
|
- |
|
|
3,103 |
|
3,023 |
0.9 |
|
2.6 |
|
||||||||
| Total Revenue |
$ |
123,048 |
$ |
(1,859 |
) |
$ |
(8,940 |
) |
$ |
112,249 |
$ |
106,575 |
15.5 |
% |
5.3 |
% |
|||||||
|
Six Months Ended
|
Six Months Ended
|
% |
|||||||||||||||||||||
|
GAAP |
Foreign Currency1 |
Hubs Acquisition2 |
Non-GAAP |
GAAP |
Change3 |
% Change Organic4 |
|||||||||||||||||
| Revenues | |||||||||||||||||||||||
|
$ |
186,397 |
$ |
- |
|
$ |
(7,783 |
) |
$ |
178,614 |
$ |
176,899 |
5.4 |
% |
1.0 |
% |
||||||||
|
|
46,104 |
|
(3,473 |
) |
|
(6,920 |
) |
|
35,711 |
|
37,516 |
22.9 |
|
(4.8 |
) |
||||||||
|
|
6,673 |
|
(31 |
) |
|
- |
|
|
6,642 |
|
7,268 |
(8.2 |
) |
(8.6 |
) |
||||||||
| Total Revenue |
$ |
239,174 |
$ |
(3,504 |
) |
$ |
(14,703 |
) |
$ |
220,967 |
$ |
221,683 |
7.9 |
% |
(0.3 |
)% |
|||||||
| 1 Revenue for the three and six-month periods ended |
|||||||||||||||||||||||
| 2 Revenue for the three and six-month periods ended |
|||||||||||||||||||||||
| 3 This column presents the percentage change from GAAP revenue for the three and six-month periods ended |
|||||||||||||||||||||||
| 4 This column presents the percentage change from GAAP revenue for the three and six-month periods ended |
|||||||||||||||||||||||
| Product Developer Information | ||||||||
| (Unaudited) | ||||||||
|
Three Months Ended |
Six Months Ended |
|||||||
|
|
|
|||||||
|
2021 |
2020 |
2021 |
2020 |
|||||
| Unique product developers and engineers served |
23,253 |
17,037 |
37,501 |
29,703 |
||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20210729005120/en/
Investor Relations Contact
Protolabs
Vice President of Investor Relations
daniel.schumacher@protolabs.com
Media Contact
Protolabs
PR & Media Strategist
brent.renneke@protolabs.com
Source: